Complementary and alternative therapies in skin cancer a literature review of biologically active compounds Review


Authors: Hidalgo, L.; Saldías-Fuentes, C.; Carrasco, K.; Halpern, A. C.; Mao, J. J.; Navarrete-Dechent, C.
Review Title: Complementary and alternative therapies in skin cancer a literature review of biologically active compounds
Abstract: Complementary and alternative medicine or therapies (CAM) are frequently used by skin cancers patients. Patient's self-administration of CAM in melanoma can reach up to 40%–50%. CAMs such as botanical agents, phytochemicals, herbal formulas (“black salve”) and cannabinoids, among others, have been described in skin cancer patients. The objective of this review article was to acknowledge the different CAM for skin cancers through the current evidence, focusing on biologically active CAM rather than mind–body approaches. We searched MEDLINE database for articles published through July 2022, regardless of study design. Of all CAMs, phytochemicals have the best in vitro evidence-supporting efficacy against skin cancer including melanoma; however, to date, none have proved efficacy on human patients. Of the phytochemicals, Curcumin is the most widely studied. Several findings support Curcumin efficacy in vitro through various molecular pathways, although most studies are in the preliminary phase. In addition, the use of alternative therapies is not exempt of risks physicians should be aware of their adverse effects, interactions with standard treatments, and possible complications arising from CAM usage. There is emerging evidence for CAM use in skin cancer, but no human clinical trials support the effectiveness of any CAM in the treatment of skin cancer to date. Nevertheless, patients worldwide frequently use CAM, and physicians should educate themselves on currently available CAMs. © 2022 Wiley Periodicals LLC.
Keywords: review; drug efficacy; nonhuman; cancer patient; melanoma; skin neoplasms; skin cancer; in vitro study; skin tumor; alternative medicine; complementary therapies; herbaceous agent; ascorbic acid; curcumin; herbal medicine; dermatologist; adverse event; non-melanoma; complementary therapy; non melanoma skin cancer; humans; human; skin cancer complementary and alternative medicine; phytochemical
Journal Title: Dermatologic Therapy
Volume: 35
Issue: 11
ISSN: 1396-0296
Publisher: Wiley Blackwell  
Date Published: 2022-11-01
Start Page: e15842
Language: English
DOI: 10.1111/dth.15842
PUBMED: 36124923
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 December 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Allan C Halpern
    396 Halpern
  2. Jun J Mao
    243 Mao
Related MSK Work